发明名称 |
Compositions for treating autism spectrum disorder |
摘要 |
<p>Subjects having at least one condition selected from the group consisting of mental retardation, Down's syndrome, fragile X syndrome and autism are treated with a composition that includes gamma-am inobutyric acid agonists and/or MI muscarinic receptor antagonists. The gamma-am inobutyric acid agonist (GABA) can be a GABA(B) agonist, such as baclofen. GABA(B) agonists can be used in combination with Group I mGluR antagonists and MI muscarinic receptor antagonists in methods of treating humans.</p> |
申请公布号 |
EP2567696(A1) |
申请公布日期 |
2013.03.13 |
申请号 |
EP20120184581 |
申请日期 |
2007.11.21 |
申请人 |
SEASIDE THERAPEUTICS, INC. |
发明人 |
CARPENTER, RANDALL L;ROBERTS, KATHRYN;BEAR, MARK F |
分类号 |
A61K31/195;A61K31/215;A61K31/428;A61P25/00;A61P43/00 |
主分类号 |
A61K31/195 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|